Cardinal Health (CAH) EBITDA Margin (2009 - 2026)
Cardinal Health's (CAH) quarterly EBITDA Margin came in at 0.84% in Q1 2026, down 49.0% year-on-year from 1.64% in Q1 2025, and down 22.47% quarter-over-quarter from 1.08% in Q4 2025.
Cardinal Health (CAH) EBITDA Margin (2009 - 2026) Analysis & Trends
Cardinal Health has disclosed EBITDA Margin across 18 years of filings, most recently posting 0.84% for Q1 2026.
- EBITDA Margin for Q1 2026 came in at 0.84%, down 49.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.92% (down 9.0% YoY), and the FY2025 annual result was 1.02%, up 47.0% from the prior year.
- EBITDA Margin came in at 0.84% for Q1 2026 at Cardinal Health, down from 1.08% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 1.33% in Q1 2025 to a low of 0.22% in Q1 2022.
- The 5-year median for EBITDA Margin is 0.71% (2025), against an average of 0.62%.
- Peak annual rise in EBITDA Margin reached 192 bps in 2022, while the deepest fall reached 142 bps in 2022.
- Cardinal Health's EBITDA Margin stood at 0.17% in 2022, then soared by 626 bps to 0.88% in 2023, then increased by 13 bps to 0.99% in 2024, then gained by 8 bps to 1.08% in 2025, then fell by 22 bps to 0.84% in 2026.
- The last three EBITDA Margin figures came in at 0.84% (Q1 2026), 1.08% (Q4 2025), and 1.04% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 2.23% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 1.63% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 0.84% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 5.40% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 7.33% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -41.35% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -0.59% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -17.29% |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.84% |
| Dec 31, 2025 | 1.08% |
| Sep 30, 2025 | 1.04% |
| Jun 30, 2025 | 0.71% |
| Mar 31, 2025 | 1.33% |
| Dec 31, 2024 | 0.99% |
| Sep 30, 2024 | 1.09% |
| Jun 30, 2024 | 0.67% |
| Mar 31, 2024 | 0.67% |
| Dec 31, 2023 | 0.88% |
| Sep 30, 2023 | -0.06% |
| Jun 30, 2023 | 0.30% |
| Mar 31, 2023 | 1.13% |
| Dec 31, 2022 | -0.17% |
| Sep 30, 2022 | 0.25% |
| Jun 30, 2022 | 0.05% |
| Mar 31, 2022 | -0.22% |
| Dec 31, 2021 | -2.09% |
| Sep 30, 2021 | 0.94% |
| Jun 30, 2021 | 0.38% |